Long-term prognostic role of uric acid in patients with ST-elevation myocardial infarction and renal dysfunction

Journal of Cardiovascular Medicine

Volumn 16, Issue 11, 2015, Pages 790-794

  Lazzeri, Chiara ^a   Valente, Serafina ^a   Chiostri, Marco ^a   Gensini, Gian Franco ^a,b  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Long term mortality; PCI; Severe renal dysfunction; STEMI; Uric acid

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; TROPONIN I; URIC ACID; BIOLOGICAL MARKER;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; BLEEDING; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; VERY ELDERLY; ACUTE KIDNEY INJURY; BLOOD; COMPLICATION; KAPLAN MEIER METHOD; KIDNEY FAILURE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PROGNOSIS;

ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; BIOMARKERS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY; URIC ACID;

EID: 84943400451     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0000000000000238     Document Type: Article

References (33)

1. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008; 359:1811-1821.
2. Vitart V, Rudan I, Hayw ard C, et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet 2008; 40:437-442.
3. Kang D. Potential role of uric acid as a risk factor for cardiovascular disease. Korean J Internal Med 2010; 25:18-20.
4. Johnson RJ, Kang DH, Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003; 41:1183-1190.
5. Gagliardi AC, Miname MH, Santos RD. Uric acid: a marker of increased cardiovascular risk. Atherosclerosis 2009; 202:11-17.
6. Lazaros G, Tsiachris D, Aznaouridis K, et al. Uric acid in-hospital cha nges predict mortality in patients with acute myocardial infarction. Nutr Metab Cardiovasc Dis 2013; 23:1202-1209.
7. Silbernagel G, Hoffmann MM, Grammer TB, et al. Uric acid is predictive of car diovascular mortality and sudden cardiac death in subjects referred for coronary angiography. Nutr Metab Cardiovasc Dis 2013; 23:46e52.
8. Lazzeri C, Valente S, Chiostri M, et al. Uric acid in the early risk stratification of ST-elevation myocardial infarction. Intern Emerg Med 2012; 7:33e9.
9. Lazzeri C, Valente S, Chiostri M, et al. Uric acid in the acute phase of ST elevation myocardial in farction submitted to primary PCI: its prognostic role and relation with inflammatory markers: a single center experience. Int J Cardiol 2010; 138:206e9.
10. Kojima S, Sakamoto T, Ishihara M, et al., Japanese Acute Coronary Syndrome Study (JACSS) Investigators. Prognostic usefulness of serum uric acid after acute myocardial infarction (the Japanese Acute Coronary Syndrome Study). Am J Cardiol 2005; 96:489e95.
11. Savarese G, Ferri C, Trimarco B, et al. Changes in serum uric acid levels and cardiovascular events: a meta-Analysis. Nutr Metab Cardiovasc Dis 2013; 23:707-714.
12. Sadeghi HM, Stone GW, Grines CL, et al. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation 2003; 108:2769-2775.
13. Kowalczyk J,Lenarczyk R,Kowals ki O,et al. Different types of renal dysfunction in patients with acute myocardial infarction treated with percutaneous coronary intervention J Interv Cardiol 2007 20 143-152.
14. Yin Z, Fang Z, Yang M, et al. Predictive value of serum uric acid levels on mortality in acute coronary syndrome patients with chronic kidney disease after drug-eluting stent implantation. Cardiology 2013; 125: 204-212.
15. Kowalczyk J, Pawel Francuz P, Swoboda R, et al. Prognostic significance of hyperuricemia in patients with different types of renal dysfunction and acute myocardial infarction treated with percutaneous coronary intervention. N ephron Clin Pract 2010; 116:c114-c122.
16. Lazzeri C, Sori A, Chiostri M, et al. Prognostic role of insulin resistance as assessed by homeostatic model assessment index in the acute phase of myocardial infarction in nondiabetic patients submitted to percutaneous coronary intervention. Eur J Anaesthesiol 2009; 26:856-862.
17. European Association for Percutaneous Cardiovascular InterventionsWijns W, Kolh P, Danchin N. et al. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the Euro pean Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2010; 31:2501-2555.
18. Tehrani DM, Seto AH. Third universal definition of myocardial infarction: update, caveats, differential diagnoses. Cleve Clin J Med 2013; 80: 777-786.
19. Levey AS, Stevens LA, Schmid CH, et al., CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150:604-612.
20. Deedwania P, Kosiborod M, Barrett E, et al., American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabet es Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2008; 117:1610-1619.
21. Valente S, Lazzeri C, Chiostri M, et al. STEMI patients: the more you bleed, the more you die: a comparison between classifications. Clin Cardiol 2011; 34:90-96.
22. Stone GW, White HD, Ohman EM, et al., Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial in vestigators. Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial. Lancet 2007; 369:907-919.
23. Kellum JA, Mehta RL, Levin A, et al., Acute Kidney Injury Network (AKIN). Development of a clinical research agenda for acute kidney injury using an international, interdisciplinary, three-step modifie d Delphi process. Clin J Am Soc Nephrol 2008; 3:887-894.
24. Kostis WJ, Deng Y, Pantazopoulos JS, et al., Myocardial Infarction Data Acquisition System (MIDAS14) Study Group. Trends in mortal ity of acute myocardial infarction after discharge from the hospital. Circ Cardiovasc Qual Outcomes 2010; 3:581-589.
25. Ferrer-Hita JJ, Dominguez-Rodriguez A, Garcia-Gonzalez MJ, Abreu-Gonzalez P. Re nal dysfunction is an independent predictor of in-hospital mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty. Int J Cardiol 2007; 118:243-245.
26. Marenzi G, Moltrasio M, Assanelli E, et al. Impact of cardiac and renal dysfunction on inhospital morbidity and mortality of patients with acute myocardial infarction undergoing primary angioplasty. Am Heart J 2007; 153:755-762.
27. Kim JY, Jeong MH, Ahn YK, et al. Decreased glomerular filtration rate is an independent predictor of inhospital mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous c oronary intervention. Korean Circ J 2011; 41:184-190.
28. Gevaert SA1, De Bacquer D, Evrard P, et al. Renal dysfunction in STEMIpatients undergoing primary angioplasty: higher prevalence but equa l prognostic impact in female patients; an observational cohort study from the Belgian STEMI registry. BMC Nephrol 2013; 14:62; doi: 10.1186/1471-2369-14-62.
29. Park SH1, Shin WY, Lee EY, et al. The impact of hyperuricemia on in-hospital mortality and incidence of acute kidney injury in patients undergoing percutaneous coronary intervention. Circ J 2011; 75:692-697.
30. Ejaz AA1, Mu W, Kang DH, et al. Could uric acid have a role in acute renal failure? Clin J Am Soc Nephrol 2007; 2:16-21.
31. Kang DH, Nakagawa T. Uric acid and chronic renal disease: possible implication of hyperuricemia on progression of renal disease. Semin Nephrol 2005; 25:43-49.
32. Lisowska-Myjak B. Serum and urinary biomarkers of acute kidney injury. Blood Purif 2010; 29:357-365.
33. Basar N, Sen N, Ozcan F, et al. Elevated serum uric acid predicts angiographic impaired reperfusion and 1-year mortality in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary interventio n. J Investig Med 2011; 59:931-937.